JASPER THERAPEUTICS, INC. (JSPRW) Operating cash flow 2020–2025
JASPER THERAPEUTICS, INC. (JSPRW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$77.2MFY2025 · since FY2020: -$18.3M → -$77.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.2M | -23.3% |
| FY2024 | -$62.6M | -20.2% |
| FY2023 | -$52.1M | -13.5% |
| FY2022 | -$45.9M | -36.2% |
| FY2021 | -$33.7M | -84.4% |
| FY2020 | -$18.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice